Reza Nassiri

Biography:

Prof. Nassiri is a hematologist graduate of the University of Paris with a fellowship training in Clinical Pharmacology at the U of M Medical Center in Ann Arbor, Michigan.  He has academic expertise in Infectious Diseases, Tropical Medicine, and Global Health.  He directs online courses in Pharmacology and Infectious Diseases, Tropical Medicine, and perspectives on Global Health.  He is currently a Professor of Pharmacology and Toxicology in Michigan State University and had served as a Professor of Family & Community Medicine.  In addition, he had served as Associate Dean of Global Health and Director of Institute of International Health.  He currently works on global health issues, particularly antibiotic resistance, COVID-19, One Health, and viruses without borders.  He has made significant contributions in various fields of medical sciences including clinical investigations, health education, and advances in academic medicine. Based on his expertise in infectious diseases including HIV/AIDS and diseases of the tropics, he had previously developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic, and Mexico. Prof. Nassiri serves on editorial board of numerus medical journals including HIV and AIDS Review, Journal of Antibiotics, and J of Global Health.  He has delivered seminar presentations on tropical diseases, HIV/AIDS, antibiotic resistance, COVID19, deadly viral epidemics and global health issues in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of One Health, building effective international partnerships in global health and technical assistance mechanisms in public health issues. He is the founder of MSUCOM Primary Health Clinic in Merida, Yucatan, Mexico.  During his tenure as MSUCOM Associate Dean of Global Health, he developed partnerships with Brazil, Mexico, Dominican Republic, Egypt, Japan, S. Korea, and Turkey.   His research interests are clinical pharmacology of anti-infective agents, deadly viral epidemics including SARS-Cov-2 (COVID-19), antibiotic resistance, prevention and control of infectious diseases, diseases of tropics, global health, and community-based public health interventions.  He had served as the Vice Chair of the AOA Bureau of Internarial Affairs for 10 years.